Question 1

What EU grants are available for the Biotechnology sector?

Accepted Answer

The European Commission offers a wide range of funding opportunities specifically designed for the Biotechnology sector. These include grants through Horizon Europe (the EU's flagship research and innovation programme with a budget of €95.5 billion), the European Innovation Council (EIC) which provides funding for breakthrough innovations, and various sector-specific initiatives. Funding types range from Research and Innovation Actions (RIA) with 100% funding rates, to Innovation Actions (IA) with 70% funding for companies, and Coordination and Support Actions (CSA) for networking and coordination activities. Our database helps you find grants that match your organization's specific needs, project stage, and funding requirements.

Question 2

How do I apply for Biotechnology grants from the EU?

Accepted Answer

Applying for EU grants in the Biotechnology sector involves several key steps. First, use Grantalist to identify suitable open calls that match your project idea and organization type. Next, carefully review the call documentation, including eligibility criteria, evaluation criteria, and the work programme. Most EU grants require you to form a consortium with partners from at least 3 different EU member states or associated countries. Once ready, you'll submit your proposal through the EU Funding & Tenders Portal, which includes a detailed description of your project, work packages, budget breakdown, and impact assessment. The evaluation process typically takes 3-5 months, after which successful applicants enter grant agreement preparation. We recommend starting your application at least 2-3 months before the deadline.

Question 3

What is the typical funding amount for Biotechnology EU grants?

Accepted Answer

EU grants for the Biotechnology sector offer diverse funding levels depending on the programme and action type. Small-scale grants through programmes like EIC Accelerator can start from €500,000 up to €2.5 million in grant funding, plus up to €15 million in equity investment. Collaborative research projects under Horizon Europe typically range from €3 million to €10 million for standard projects, while some large-scale flagship initiatives can exceed €20 million. SMEs and startups often benefit from higher funding rates (up to 70% for Innovation Actions compared to large companies) and access to specialized instruments. The exact amount depends on the specific call topic, project scope, consortium size, and type of activities proposed.

Question 4

Who is eligible for Biotechnology EU grants?

Accepted Answer

Eligibility for Biotechnology EU grants extends to a wide range of organizations. Legal entities from EU member states and associated countries (including the UK for some programmes, Norway, Switzerland, and others) are typically eligible. This includes universities and research institutions, large enterprises and multinational corporations, small and medium-sized enterprises (SMEs) with fewer than 250 employees, startups and scale-ups, public bodies and NGOs, and international organizations. Some calls specifically target certain organization types, such as SME-only calls or academic-focused research grants. Third-country participation is possible in many programmes, though often without EU funding.

EU Grants for Biotechnology

Boosting innovation for a better understanding of the determinants of health

Innovative technologies and tools for exploration and data modelling of raw materials (RIA)

Mapping and service finder for Technology Infrastructures (CSA)

Cooperation on innovative advanced materials with Japan (CSA)

Circular innovative advanced materials: facilitating the transition from design to markets (RIA) (Innovative Advanced Materials for the EU and Made in Europe partnerships)

Boosting innovation for better assessment of the added value of innovative integrated healthcare solutions

Thematic Networks of Excellence for AI in Science (RAISE pilot) (RIA)

‘Proof of market’ to improve valorisation and commercialisation of Horizon generated R&I results (IA)

Accelerating the discovery and development of chemicals and innovative advanced materials through digitalisation and artificial intelligence (IA) (Innovative Advanced Materials for the EU partnership)

Boosting innovation through better integration of fragmented health R&I efforts

Monitoring of secondary raw materials (CSA)

Erasmus for Young Entrepreneurs

Advanced manufacturing for key products (IA) (Made in Europe partnership)

Optimise the usage of resources in a circular economy (RIA) (Processes4Planet and Clean Steel partnerships)

Technologies for innovative extraction of critical raw materials (RIA)

Boosting innovation through exploitation of digitalisation and data exchange in healthcare

Attracting management talent for capacity building for Technology Infrastructures staff members (CSA)

Protection of the euro against counterfeiting

Boosting innovation for people-centred integrated healthcare solutions

Thematic Networks of Excellence for AI in Science – Agriculture and Environmental Pollution (RAISE pilot)

Efficient capture / purification / utilisation of CO2 for the production of competitive products (RIA) (Processes4Planet partnership)

Pilot access schemes to Technology Infrastructures for European startups, scaleups and innovative SMEs (CSA)

Enhancing industry-academia knowledge exchange in Social Sciences and Humanities (SSH) (CSA)

Improving availability of secondary raw materials through recycling (IA)

Call for proposals for action grants to promote judicial cooperation in civil and criminal matters

Agrip-simple-2026-tc-org-sust

Agrip-simple-2026-im-fresh-fv

Agrip-multi-2026-im-fresh-fv

Agrip-multi-2026-tc-org-sust

Agrip-multi-2026-im

Frequently Asked Questions About Biotechnology EU Grants